Ardelyx EBITDA Margin 2013-2025 | ARDX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Ardelyx ebitda margin from 2013 to 2025. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Ardelyx EBITDA Margin 2013-2025 | ARDX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Ardelyx ebitda margin from 2013 to 2025. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$72.3B
Zoetis (ZTS)	$68.6B
Takeda Pharmaceutical (TAK)	$47.6B
Daiichi Sankyo, - (DSNKY)	$46.4B
BeOne Medicines - (ONC)	$32.7B
Sandoz Group AG (SDZNY)	$27.7B
Summit Therapeutics (SMMT)	$18.1B
Merck (MKKGY)	$16.3B
Shionogi (SGIOY)	$14.8B
United Therapeutics (UTHR)	$13.9B
Neurocrine Biosciences (NBIX)	$13.8B
IPSEN (IPSEY)	$11.6B
Orion OYJ (ORINY)	$11.2B
Madrigal Pharmaceuticals (MDGL)	$9.7B
Eisai (ESAIY)	$9.1B
Corcept Therapeutics (CORT)	$7.3B
Stevanato Group S.p.A (STVN)	$7.1B
Ionis Pharmaceuticals (IONS)	$6.8B
Grifols, S.A (GRFS)	$6.8B
Ono Pharmaceutical (OPHLF)	$5.7B
Hikma Pharmaceuticals Plc (HKMPF)	$5.4B
Soleno Therapeutics (SLNO)	$3.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$3B
Crinetics Pharmaceuticals (CRNX)	$2.9B
Hypermarcas (HYPMY)	$2.8B
Procaps Group, S.A (PROCF)	$2.8B
NewAmsterdam Pharma (NAMS)	$2.7B
Catalyst Pharmaceuticals (CPRX)	$2.5B
Centessa Pharmaceuticals (CNTA)	$2.2B
Ocular Therapeutix (OCUL)	$2.2B